In the previous studies, we demonstrated that the synthesis of vascular endothelial growth factor (VEGF) and growth of MM in xenograf models [3] were significantly inhibited by using small-interfering RNA (siRNA), which makes us believe that the modulation of aberrant signaling pathways in MM cell will probably provide more effective and potential nontoxic therapy for MM. Here, VEGFA is linked to Miyoshi myopathy.